Clinical experience with recombinant factor vila in patients with thrombocytopenia

Pathophysiology of Haemostasis and Thrombosis

Volumn 26, Issue , 1996, Pages 159-164

  Kristemen, Jdrgen ^a   Killander, Andreas ^a   Hippe, Erik ^c   Helleberg, Carsten ^c   Ellegard, Jorgen ^d   Holm, Mette ^d   Kutti, Jack ^b   Mellqvist, Ulf Henrik ^b   Erik Johansson, Jan ^b   Glazer, Steven ^e   Hedner, Vila ^e  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Herlev Sygchus   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e NOVO NORDISK A S   (Denmark)

Author keywords

Bleeding time; Recombinant factor VIla; Thrombocytopenia

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; AGED; BLEEDING; BLEEDING TIME; CONFERENCE PAPER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VIIA; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; THROMBOCYTOPENIA;

EID: 9044221759     PISSN: 14248832     EISSN: 14248840     Source Type: Journal    
DOI: 10.1159/000217260     Document Type: Article

References (14)

1. Macik BG. Hohnekcr J, Roberts HR, Griffin AM: The use of recombinant activated factor VU for treatment of a retropharyngeal haemorrhage in a hemophilic patient with a high titer inhibitor. Am J Hematol 1989:32:232.
2. Ingerslev J. Feldstedt M, Sindet-Pedersen S: Control of haemostasis with recombinant factor Vila in patient with inhibitor to factor VIII. Lancet 1991;vol i:831.
3. Ivy AC, Shapiro PF, Melnick P: The bleeding tendency in jaundice. Surg Gynecol Obstet 1935,60:781.
4. Weiss HJ. Lagcs B: Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 1988; 629:635.
5. Hedner U. Bcrgqvist D, Ljungberg J, Nilsson B: Haemostatic effect of factor Vila in trombocytopenic rabbits. Blood 1985;66(suppl 1):1043.
6. Hoffman M. Monroe DM, Roberts HR: Human monocytes support factor X activation by factor Vila, independent of tissue factor: Implications for the therapeutic mechanism of high-dose factor Vila in hemophilia. Blood 1994:83/3:38-42.
7. Lindahl AK, Nordfang O. Wild-goose P, Kelly AB. Harker LA, Hanson SR: Antithrombotic effects of a truncated tissue factor pathway inhibitor (TFPI) in baboons (abstract). Thromb Haemost 1993;69:742.
8. Harker LA, Hanson SR, Kelly AB, Lumsden AB, Wilcox JN. Ezban M, Hedner U: Prevention of injury-induced vascular stenosis by transient inhibition of tissue factor (TF)-de-pendent thrombosis (abstract). Thromb Haemost 1995:73:1378.
9. Colton T: Statistics in Medicine. Boston, Little, Brown, 1974.
10. Hows JM, Brozovic B: Platelet and granulocyte transfusions. BMJ 1990:300:520.
11. Hedner U: Factor Vila in the treatment of haemophilia. Blood Coagul Fibrinolysis 1990;1:307-317.
12. Rao LVM. Rapaport SI: Factor Vila-catalyzed activation of factor X independent of tissue factor: Its possible significance for control of hemophilic bleeding by infused factor Vila. Blood 1990:75:1069-1073.
13. Gringeri A, Santagostino E, Man-nucci PM: Failure of recombinant activated factor VII during surgery in a hemophilic with high-titer factor VIII antibody. Haemostasis 1991;21:1-4.
14. Ingerslev J, Sneppen O. Knudsen L, Sindet-Pedersen S: Hemostatic efficacy of recombinant factor Vila in surgical interventions in hemophilia A patients with inhibitors. 2nd Int Symp Inhib Coagulation Factors, UNC, Nov. 3-5,1993.